EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 621 (2025) E3S Web Conf., 621 (2025) 02002 References
Open Access
Issue
E3S Web Conf.
Volume 621, 2025
Second International Conference on Green Energy, Environmental Engineering and Sustainable Technologies 2024 (ICGEST 2024)
Article Number 02002
Number of page(s) 10
Section Green Sustainable Process for Chemical and Biological Science
DOI https://doi.org/10.1051/e3sconf/202562102002
Published online 19 March 2025
  1. Alsaedi, A. A. H., Al-Ali, S. J., & Waheed, S. (2021). The Association of The High-Mobility Group Box 1 Gene and Its Product with Rheumatoid Arthritis in Basra Province-Iraq. University of Thi-Qar Journal of Science, 8(1), 107-112. [Google Scholar]
  2. Mohammed, C. J., Lamichhane, S., Connolly, J. A., Soehnlen, S. M., Khalaf, F. K., Malhotra, D., ... & Kennedy, D. J. (2022). A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease. Antioxidants, 11(3), 590. [CrossRef] [PubMed] [Google Scholar]
  3. Bassu, S., Mangoni, A. A., Satta, R., Argiolas, D., Carru, C., & Zinellu, A. (2023). Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis. Clinical and Experimental Medicine, 23(2), 301-311. [Google Scholar]
  4. Mahrooz, A., & Mackness, M. (2020). Epigenetics of paraoxonases. Current Opinion in Lipidology, 31(4), 200-205. [Google Scholar]
  5. Micke, O., Vormann, J., Kraus, A., & Kisters, K. (2021). Serum magnesium: Time for a standardized and evidence-based reference range. Magnesium research, 34(2), 84-89. [PubMed] [Google Scholar]
  6. Al Wadee, Z., Ooi, S. L., & Pak, S. C. (2022). Serum magnesium levels in patients with obstructive sleep apnoea: a systematic review and meta-analysis. Biomedicines, 10(9), 2273. [PubMed] [Google Scholar]
  7. Human Paraoxonase-1 (PON1) ELISA Kit (Enzyme activity) www.SUNLONGBIOTECH.COM [Google Scholar]
  8. Lewińska, I., Ścibisz, M., & Tymecki, Ł. (2024). Microfluidic paper-based analytical device for simultaneous determination of calcium and magnesium ions in human serum. Analytica Chimica Acta, 1308, 342639. [CrossRef] [PubMed] [Google Scholar]
  9. Abd, H. N., & Hassan, A. B. (2021). Evaluation of Paraoxonase-1 (PON-1) in Relation with Rheumatoid Arthritis Patients. Annals of the Romanian Society for Cell Biology, 25(6), 13902-13911. [Google Scholar]
  10. El-Banna, H., & Jiman-Fatani, A. (2014). Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC musculoskeletal disorders, 15, 1-7. [Google Scholar]
  11. Charles‐Schoeman, C., Lee, Y. Y., Shahbazian, A., Gorn, A. H., FitzGerald, J., Ranganath, V. K., ... & Reddy, S. T. (2013). Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. Arthritis & Rheumatism, 65(11), 2765-2772. [CrossRef] [PubMed] [Google Scholar]
  12. Rodríguez‐Carrio, J., López‐Mejías, R., Alperi‐López, M., López, P., Ballina‐García, F. J., González‐Gay, M. Á., & Suárez, A. (2016). Paraoxonase 1 activity is modulated by the rs662 polymorphism and IgG anti–high‐density lipoprotein antibodies in patients with rheumatoid arthritis: potential implications for cardiovascular disease. Arthritis & Rheumatology, 68(6), 1367-1376. [CrossRef] [PubMed] [Google Scholar]
  13. Zaragoza-García, O., Guzmán-Guzmán, I. P., Moreno-Godínez, M. E., Navarro-Zarza, J. E., Antonio-Vejar, V., Ramírez, M., & Parra-Rojas, I. (2021). PON-1 haplotype (-108C> T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients. Clinical Rheumatology, 40, 741-752. [Google Scholar]
  14. Wu, C., Wu, D., Lin, M., & Zhong, Y. (2018). The associations between paraoxonase 1 L55M/Q192R genetic polymorphisms and the susceptibilities of diabetic macroangiopathy and diabetic microangiopathy: a meta-analysis. Diabetes Therapy, 9, 1669-1688. [Google Scholar]
  15. El-Banna, H., & Jiman-Fatani, A. (2014). Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC musculoskeletal disorders, 15, 1-7. [Google Scholar]
  16. Tang, W. W., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F., Erdmann, J., ... & Hazen, S. L. (2012). Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arteriosclerosis, thrombosis, and vascular biology, 32(11), 2803-2812. [CrossRef] [PubMed] [Google Scholar]
  17. Shahmohamadnejad, S., Vaisi-Raygani, A., Shakiba, Y., Kiani, A., Rahimi, Z., Bahrehmand, F., ... & Pourmotabbed, T. (2015). Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report. Clinical Biochemistry, 48(1-2), 63-69. [Google Scholar]
  18. Fonseca, L. J. S. D., Nunes-Souza, V., Goulart, M. O. F., & Rabelo, L. A. (2019). Oxidative stress in rheumatoid arthritis: What the future might hold regarding novel biomarkers and add‐on therapies. Oxidative medicine and cellular longevity, 2019(1), 7536805. [CrossRef] [Google Scholar]
  19. Baskol, G., Demir, H., Baskol, M., Kilic, E., Ates, F., Kocer, D., & Muhtaroglu, S. (2005). Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clinical biochemistry, 38(10), 951-955. [Google Scholar]
  20. Zuin, M., Rosta, V., Trentini, A., Bosi, C., Zuliani, G., & Cervellati, C. (2023). Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis. Chemico-Biological Interactions, 382, 110601. [Google Scholar]
  21. Huang, T., Yan, G., & Guan, M. (2020). Zinc homeostasis in bone: Zinc transporters and bone diseases. International journal of molecular sciences, 21(4), 1236. [Google Scholar]
  22. Geiger, H., & Wanner, C. (2012). Magnesium in disease. Clinical kidney journal, 5(Suppl_1), i25-i38. [Google Scholar]
  23. Rondanelli, M., Faliva, M. A., Tartara, A., Gasparri, C., Perna, S., Infantino, V., ... & Peroni, G. (2021). An update on magnesium and bone health. Biometals, 34(4), 715-736. [PubMed] [Google Scholar]
  24. Zhao J, Guo S, Schrodi SJ, He D. 2022. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: implication, prospects, and perspectives. Front Immunol. 13:930278. doi: 10.3389/fimmu.2022.930278 [Google Scholar]
  25. Brenner, M., Laragione, T., & Gulko, P. S. (2017). Short-term low-magnesium diet reduces autoimmune arthritis severity and synovial tissue gene expression. Physiological Genomics, 49(4), 238-242. [Google Scholar]
  26. Laragione, T., Harris, C., Azizgolshani, N., Beeton, C., Bongers, G., & Gulko, P. S. (2023). Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome. EBioMedicine, 92. [Google Scholar]
  27. Yao, H., Xu, J., Wang, J., Zhang, Y., Zheng, N., Yue, J., ... & Qin, L. (2021). Combination of magnesium ions and vitamin C alleviates synovitis and osteophyte formation in osteoarthritis of mice. Bioactive materials, 6(5), 1341-1352. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.